The Quality Lowdown: Diversion, Cross-Contamination And PR Mix-Ups
Executive Summary
McKesson meets with US FDA over opioid diversion warning letter, while UK MHRA takes risk-based approach to cross-contamination recalls and firm says it’s the other Guardian Pharmacy.